ArticleJournal of cellular physiology2026
RETRACTION: MicroRNA-6869-5p Acts as a Tumor Suppressor via Targeting TLR4/NF-κB Signaling Pathway in Colorectal Cancer.
Article in Journal of cellular physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retraction"MicroRNA-6869-5p Acts as a Tumor Suppressor via Targeting TLR4/NF-κB Signaling Pathway in Colorectal Cancer," by S. Yan, G. Liu, C. Jin, Z. Wang, Q. Duan, J. Xu, and D. Xu, Journal of Cellular Physiology 233, no. 9 (2018): 6660-6668, https://doi.org/10.1002/jcp.26316. The above article, published online on December 5, 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Robert Heath; and Wiley Periodicals LLC. The retraction has been agreed due to concerns raised by third parties. Specifically, Figure 5A presents panels previously published by the author group in a different scientific context. Furthermore, scientific inconsistencies have been identified related to the patient data. The authors did not respond to our request for comments. Accordingly, the article has been retracted as the editors have lost confidence in the accuracy and integrity of the whole body of data and consider the conclusions of the article invalid. The authors were informed of the retraction decision but were unavailable for final confirmation.
Identifiers
41982107What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.